Clinical trial

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

NCT03959514

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-12

PhasePHASE1

Study timeline

Study start (actual)2019-04-12Date precision: day

Registry last updated2019-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

NovoRapidBIOLOGICAL

FiaspBIOLOGICAL

AT247BIOLOGICAL

Sponsors & collaborators

Arecor Limitedlead sponsor

Mapped research locations

GrazAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03959514 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.